Infectious Disease Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Infectious Disease Diagnostics Market by Product Type (Assays, Kits, & Reagents, Instruments, Services & Software), Testing Type (Laboratory Testing, POC Testing), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, Others), Disease Type (COVID-19, HIV, HAIs, Hepatitis, STDs, HPV, TB, Influenza, Others), End User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Infectious Disease Diagnostics Market size was estimated at USD 32.2 Bn in 2021, growing at a CAGR of 6.9% during the forecast period 2021-2027. Infectious disease diagnostics are the procedures for the identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making the right medical decisions. Infectious diseases are caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. This market can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods. Geographically, the global infectious disease diagnostics market is in the flourishing stage, with the development of novel technologies by various players in the market. The increasing prevalence of the deadly infectious disease will drive the growth of the global infectious disease diagnostics market over the forecast period. For instance, according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection worldwide. Innovation of technologically advanced devices with quick results, ease of usage, accuracy, and low cost are expected to boost the global infectious disease diagnostics market. For instance, in 2013, Abbott Molecular introduced a new range of real-time assays for hepatitis B virus, and hepatitis C virus infections on its m2000 platform. The majority of companies are making efforts to develop and commercialize cost-effective tools for infectious disease diagnostics. Nowadays, the gold standard tests are available for sexually transmitted disease and bacterial infection diagnosis, and these tests are expected to replace by molecular techniques in the future.

Infectious Disease Diagnostics Market

MARKET SUMMARY
-
6.9% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.9%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Infectious Disease Diagnostics Market

  • In 2016, Abbott unveiled Alinity, its unified family of innovative next-generation diagnostics system across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics
  • In 2015, Bio-Rad FDA has approved Bio-Rad’s BioPlex 2200 human immunodeficiency virus (HIV) Antigen-Antibody assay, used for detection of HIV antibodies and HIV antigens
  • In 2014, DiaSorin launched the new molecular diagnostic test for the detection of Toxoplasmosis.
Market Key Players
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • bioMérieux SA (France)
  • Thermo Fischer Scientific (U.S.)
  • Abbott Laboratories (U.S.),
  • Bio-Rad Laboratories Inc. (U.S.)
  • Becton, Dickinson & Company (U.S.)
  • DiaSorin S.p.A. (Italy)
Drivers And Restraints

Infectious Disease Diagnostics Market

The key drivers for the growth of the infectious disease diagnostics market increase in the prevalence of dengue, malaria, and HIV, rise in the preference for rapid diagnosis, increase in government funding for the establishment of diagnostic centers, and technological advancements in diagnostic procedures expected to fuel the infectious disease diagnostics market. Furthermore, increase in the R&D activities for newer assays, changing demographics around the globe, and advances in healthcare infrastructure are expected to boost the infectious disease diagnostics market. However, high cost for the diagnostic procedures, lack of awareness about the novel diagnostic procedures, dearth of skilled professionals to perform diagnostic tests, and lack of reimbursement policies for several diagnostic test might hamper the infectious disease diagnostics market growth over the forecast period.


North-America got significant share

Infectious Disease Diagnostics Market

Geographically, global infectious disease diagnostics market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global infectious disease diagnostics market followed by Europe and Asia-Pacific. The largest share of North-America region is due to increase in the prevalence of infectious diseases especially in U.S. According to UNAIDS, in 2012, about 1.3 Mn patients were diagnosed with HIV in the U.S. These statistics are likely to increase over the coming years, if suitable treatment options are not provided in time. The European region is expected to emerge as significant market owing to improved healthcare infrastructure, and increase in prevalence of bacterial and viral diseases (according to WHO European Region, at the end of 2015, about 13.3 Mn people live with chronic hepatitis B, an estimated 15 Mn people with hepatitis C, and more than 2 Mn people with HIV), which are expected to fuel the growth of the market in European region. Moreover, Asia-Pacific is a key region for the growth of global infectious disease diagnostics during the forecast period, due to the high prevalence of infectious diseases,  and increasing in healthcare expenditure. Moreover, due to increase in incidence and prevalence of infectious diseases such as bacterial infections and sexually transmitted diseases and rise in population expected to drive significant growth of the market in Asia-Pacific region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Segmentation

Infectious Disease Diagnostics Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Infectious Disease Diagnostics Market Introduction
2.1. Global Infectious Disease Diagnostics Market – Taxonomy
2.2. Global Infectious Disease Diagnostics Market –Definitions
2.2.1. Product Type
2.2.2. Testing Type
2.2.3. Technology
2.2.4. Disease Type
2.2.5. End User
3. Global Infectious Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamic Factors – Impact Analysis
3.6. Global Infectious Disease Diagnostics Market – Competition Landscape
4. Global Infectious Disease Diagnostics Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Infectious Disease Diagnostics Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Assays, Kits, & Reagents
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services & Software
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Infectious Disease Diagnostics Market, By Testing Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Laboratory Testing
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. POC Testing
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Infectious Disease Diagnostics Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Immunodiagnostics
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinical Microbiology
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. PCR
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. INAAT
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. DNA Sequencing & NGS
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Infectious Disease Diagnostics Market Forecast, By Disease Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
8.1. COVID-19
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. HIV
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. HAIs
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hepatitis
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. STDs
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. HPV
8.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
8.7. TB
8.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.7.3. Market Opportunity Analysis
8.8. Influenza
8.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.8.3. Market Opportunity Analysis
8.9. Others
8.9.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.9.3. Market Opportunity Analysis
9. Global Infectious Disease Diagnostics Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
9.1. Diagnostic Laboratories
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Hospitals & Clinics
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Academic Research Institutes
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Others
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Infectious Disease Diagnostics Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Region, 2022 – 2028
11. North America Infectious Disease Diagnostics MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Assays, Kits, & Reagents
11.1.2. Instruments
11.1.3. Services & Software
11.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Laboratory Testing
11.2.2. POC Testing
11.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Immunodiagnostics
11.3.2. Clinical Microbiology
11.3.3. PCR
11.3.4. INAAT
11.3.5. DNA Sequencing & NGS
11.3.6. Others
11.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. COVID-19
11.4.2. HIV
11.4.3. HAIs
11.4.4. Hepatitis
11.4.5. STDs
11.4.6. HPV
11.4.7. TB
11.4.8. Influenza
11.4.9. Others
11.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Diagnostic Laboratories
11.5.2. Hospitals & Clinics
11.5.3. Academic Research Institutes
11.5.4. Others
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
11.8. North America Infectious Disease Diagnostics Market Dynamics – Trends
12. Europe Infectious Disease Diagnostics Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
12.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Assays, Kits, & Reagents
12.1.2. Instruments
12.1.3. Services & Software
12.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Laboratory Testing
12.2.2. POC Testing
12.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Immunodiagnostics
12.3.2. Clinical Microbiology
12.3.3. PCR
12.3.4. INAAT
12.3.5. DNA Sequencing & NGS
12.3.6. Others
12.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. COVID-19
12.4.2. HIV
12.4.3. HAIs
12.4.4. Hepatitis
12.4.5. STDs
12.4.6. HPV
12.4.7. TB
12.4.8. Influenza
12.4.9. Others
12.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Diagnostic Laboratories
12.5.2. Hospitals & Clinics
12.5.3. Academic Research Institutes
12.5.4. Others
12.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End Userand Country, 2022 – 2028
12.8. Europe Infectious Disease Diagnostics Market Dynamics – Trends
13. Asia-Pacific Infectious Disease Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Assays, Kits, & Reagents
13.1.2. Instruments
13.1.3. Services & Software
13.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Laboratory Testing
13.2.2. POC Testing
13.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Immunodiagnostics
13.3.2. Clinical Microbiology
13.3.3. PCR
13.3.4. INAAT
13.3.5. DNA Sequencing & NGS
13.3.6. Others
13.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. COVID-19
13.4.2. HIV
13.4.3. HAIs
13.4.4. Hepatitis
13.4.5. STDs
13.4.6. HPV
13.4.7. TB
13.4.8. Influenza
13.4.9. Others
13.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Diagnostic Laboratories
13.5.2. Hospitals & Clinics
13.5.3. Academic Research Institutes
13.5.4. Others
13.6. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country,2022 – 2028
13.8. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends
14. Latin America Infectious Disease Diagnostics Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
14.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Assays, Kits, & Reagents
14.1.2. Instruments
14.1.3. Services & Software
14.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Laboratory Testing
14.2.2. POC Testing
14.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Immunodiagnostics
14.3.2. Clinical Microbiology
14.3.3. PCR
14.3.4. INAAT
14.3.5. DNA Sequencing & NGS
14.3.6. Others
14.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. COVID-19
14.4.2. HIV
14.4.3. HAIs
14.4.4. Hepatitis
14.4.5. STDs
14.4.6. HPV
14.4.7. TB
14.4.8. Influenza
14.4.9. Others
14.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Diagnostic Laboratories
14.5.2. Hospitals & Clinics
14.5.3. Academic Research Institutes
14.5.4. Others
14.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
14.8. Latin America Infectious Disease Diagnostics Market Dynamics – Trends
15. Middle East and Africa Infectious Disease Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
15.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
15.1.1. Assays, Kits, & Reagents
15.1.2. Instruments
15.1.3. Services & Software
15.2. Testing Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Laboratory Testing
15.2.2. POC Testing
15.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Immunodiagnostics
15.3.2. Clinical Microbiology
15.3.3. PCR
15.3.4. INAAT
15.3.5. DNA Sequencing & NGS
15.3.6. Others
15.4. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. COVID-19
15.4.2. HIV
15.4.3. HAIs
15.4.4. Hepatitis
15.4.5. STDs
15.4.6. HPV
15.4.7. TB
15.4.8. Influenza
15.4.9. Others
15.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Diagnostic Laboratories
15.5.2. Hospitals & Clinics
15.5.3. Academic Research Institutes
15.5.4. Others
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 – 2028
15.8. MEA Infectious Disease Diagnostics Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Abbott Laboratories
16.2.2. Becton Dickinson and Company
16.2.3. bioMerieus SA
16.2.4. Bio-Rad Laboratories
16.2.5. Danaher Corporation
16.2.6. F Hoffman-La Roche
16.2.7. Hologic Inc.
16.2.8. Luminex Corporation
16.2.9. Qiagen Inc.
16.2.10. Thermo Fisher Scientific Inc.
16.2.11. LumiraDx
17. Research Methodology
18. Key Assumptions and Acronyms

Report

Company Profile

  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc
  • Thermo Fisher Scientific Inc.
  • LumiraDx

Description

Infectious Disease Diagnostics Market size was estimated at USD 32.2 Bn in 2021, growing at a CAGR of 6.9% during the forecast period 2021-2027. Infectious disease diagnostics are the procedures for the identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making the right medical decisions. Infectious diseases are caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. This market can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods. Geographically, the global infectious disease diagnostics market is in the flourishing stage, with the development of novel technologies by various players in the market. The increasing prevalence of the deadly infectious disease will drive the growth of the global infectious disease diagnostics market over the forecast period. For instance, according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection worldwide. Innovation of technologically advanced devices with quick results, ease of usage, accuracy, and low cost are expected to boost the global infectious disease diagnostics market. For instance, in 2013, Abbott Molecular introduced a new range of real-time assays for hepatitis B virus, and hepatitis C virus infections on its m2000 platform. The majority of companies are making efforts to develop and commercialize cost-effective tools for infectious disease diagnostics. Nowadays, the gold standard tests are available for sexually transmitted disease and bacterial infection diagnosis, and these tests are expected to replace by molecular techniques in the future.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX